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Multidrug resistance of murine leukaemic cell line L1210/VCR (obtained by adaptation of parental drug-sensitive L1210 cells to
vincristine) is associated with overexpression of mdr1 gene product P-glycoprotein (Pgp)—the ATP-dependent drug efflux pump. 31P-NMR
spectra of L1210 and L1210/VCR cells (the latter in the presence of vincristine) revealed, besides the decrease of ATP level, a considerable
lower level of UDP-saccharides in L1210/VCR cells. Histochemical staining of negatively charged cell surface binding sites (mostly sialic
acid) by ruthenium red (RR) revealed a compact layer of RR bound to the external coat of sensitive cells. In resistant cells cultivated in the
absence or presence of vincristine, the RR layer is either reduced or absent. Consistently, resistant cells were found to be less sensitive to
Concanavalin A (ConA). Moreover, differences in the amount and spectrum of glycoproteins interacting with ConA-Sepharose were
demonstrated between sensitive and resistant cells. Finally, the content of glycogen in resistant cells is lower than in sensitive cells. All the
above facts indicate that multidrug resistance of L1210/VCR cells mediated predominantly by drug efflux activity of Pgp is accompanied by a
considerable depression of oligo- and/or polysaccharides biosynthesis.
D 2003 Elsevier B.V. All rights reserved.Keywords: Multidrug resistance; P-glycoprotein; L1210 cell line; Concanavalin A; Ruthenium red; Oligo- (poly-)saccharides
1. Introduction ca-alkaloids, anthracyclins, etc., [6] and is associated with aMultidrug resistance (MDR) of neoplastic cells is the
phenotype when exposures of cells to single cytotoxic drug
induce cross-resistance to a broad group of structurally and
functionally unrelated drugs. The increased expression of the
mdr1 gene, encoding the P-glycoprotein (Pgp)—170-kDa
plasma membrane integral glycoprotein, has often been
found to be causally related to the MDR phenotype [1–5].
The overexpression of Pgp can occur via numerous types of
stimulation, especially anticancer drug themselves like vin-0925-4439/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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E-mail address: usrdtylo@savba.sk (A. Breier).poor response of neoplastic cells to chemotherapy [7]. Pgp is
an ATP-dependent extrusion pump (with a broad substrate
specificity) capable of recognition and efflux of several
substances involving anti-tumour drugs out from cells,
thereby decreasing their intracellular concentration and re-
ducing their cytotoxic efficacy [8]. To secure the Pgp-
mediated drug efflux MDR cells have to produce a large
amount of energy. Consistent with this, a greater requirement
for ATP and an increased level of glycolysis were observed
in several MDR cells [9–11]. Changes in enzymes of
glycolytic and pentose phosphate pathways have been found
to be associated with MDR cells [8,12,13]. In our laboratory,
the MDR murine leukaemic cell line L1210/VCR was used,
obtained by adaptation of sensitive parental L1210 cells
cultured in progressively increased concentrations of vin-
cristine [14]. This cell line exhibits MDR phenotype associ-
ated with: (i) cross-resistance to vinblastine, doxorubicin,
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tomycin C [15,16]; (ii) overexpression of Pgp [14,17]; (iii)
sensitivity to well-known inhibitors of Pgp-mediated MDR
like verapamil, trifluoperazine, cinchocaine and others [18];
(iv) increased level and activity of p38-mitogen-activated
protein kinase [19]; (v) sensitivity to inhibitors of mitogen-
activated protein kinase cascades like SB203580 (p38-mito-
gen-activated protein kinase), PD98059 and UO126 (specif-
ic inhibitors of extracellular signal-regulated protein kinase
pathways [19,20]).
We described decreases in accumulation and retention
of cytotoxic drugs by these cells for vincristine and
doxorubicin [21]. The MDR character of L1210/VCR
cells is not associated with changes in the glutathione
detoxification pathway [15]. Following exposition to vin-
cristine, increased utilisation of oxygen, increased glucose
incorporation and a higher degree of mitochondrial con-
densation were observed in L1210/VCR cells relative to
L1210 cells [14,22]. These facts suggest an acceleration of
energy metabolism due to a large amount of energy
consumed by the process of drug efflux. It is reasonable
to expect differences in courses of several anabolic path-
ways including the synthesis of oligo- and polysacchar-
ides. Therefore, the aim of the present study was to test if
multidrug resistant L1210/VCR cells differ from parental
sensitive L1210 cells also in oligo- and polysaccharides
levels.2. Materials and methods
2.1. Chemicals
Used chemicals were purchased from the following
sources: L-glutamine—Life Technologies Ltd. (Paisley,
Scotland); gentamycin—Pharmachim (Bulgaria); vincris-
tine—Gedeon Richter Co. (Hungary); amyloglucosidase
(70 U/mg), glucose oxidase (245 U/mg) and peroxidase
(590 U/mg)—Serva (Heidelberg, Germany); ruthenium red
(RR), desiccated firefly tails (lanterns), UDP-glucose dehy-
drogenase, UDP-glucose, NAD and ATP—Sigma-Aldrich
Chemie GmbH (Steinheim, Germany); glutaraldehyde—
Polysciences (Warrington, USA); OsO4—Serva; Durcu-
pan—Fluka (Buchs, Switzerland); a-methyl-D-mannopyra-
noside—Fluka; ConA-Sepharose CL4B—Amersham
Pharmacia Biotech (Germany). Other chemicals (analytical
grade) were obtained from Sigma (St. Louis, USA),
Lachema (Brno, Czech Republic) or Slavus (Bratislava,
Slovak Republic).
2.2. Cells and cultivation conditions
Two sublines of murine leukaemic cell line L1210
were used in our experiments: the sensitive (parental) cell
line L1210, and the multidrug resistant cell subline
L1210/VCR. The resistant cell subline was obtained bylong-term adaptation of L1210 cells to vincristine [14].
Cell cultivation was carried out in standard RPMI 1640
medium (Life Technologies) supplemented with heat-inac-
tivated foetal bovine serum (4%, Life Technologies),
glutamine (1 mg/ml) and gentamycin (1 mg/l) in an
atmosphere of 5% CO2 at 37 jC. Cell sensitivity to
vincristine was ascertained as IC50 value for vincristine
after cultivation of cells in medium containing vincristine
in concentration range 0–2 mg/l. In one experimental set,
L1210/VCR cells were recultivated 15 times in medium in
the absence of vincristine for estimation of stability of
vincristine resistance of L1210/VCR cells. Sensitive
L1210 cells (S) and multidrug resistant L1210/VCR cells
cultivated in the absence (R) or presence of 0.2 mg/l of
vincristine (Rv) were compared in estimations mentioned
below.
2.3. Detection of mRNA encoding Pgp
Total cellular RNA was extracted from sensitive and
resistant cells using LiCl/urea method [23]. RT-PCR was
performed with the Gene Amp RNA PCR kit (Perkin Elmer
via Rocher Molecular Systems Inc., Branchburg, NJ, USA)
as described by Stein et al. [24]. We used the following PCR
primers: 5V-CCC ATC ATT GCA ATA GCA GG-3Vand 5V-
GTT CAA ACT TCT GCT CCT GA-3V for mdr1, which
yield a 167 bp product [25,26]; 5V-ATC ATG TTT GAG
ACC TTC AA-3Vand 5V-CAT CTC TTG CTC GAA GTC
CA-3V for h-actin giving a 316 bp product. The PCR
products were separated on 1.5% agarose gel (Gibco) and
visualised with ethidium bromide.
2.4. Western blot determination of Pgp
The overexpression of membrane Pgp was determined by
Western blot using monoclonal antibody C219 (Centrocor,
USA) by the following procedure: cells were disrupted and a
crude membrane fraction was prepared as described by
Hamada and Tsuruo [27]. Membrane proteins (35 Ag per
lane) from the crude membrane fraction were separated by
SDS-PAGE [28]. Proteins were transferred by electroblotting
to nitrocellulose (Amersham, UK) by the method of Towbin
et al. [29]. Pgp on the membrane was detected by C219
monoclonal antibody and an anti-mouse secondary antibody
linked with horseradish peroxidase using ECL detection
system.
2.5. 31P-NMR measurements of intact cells
The cells were pelleted by centrifugation (3 min at
1200 g), washed two times in PBS and 4–8 108 cells
were resuspended in physiological solution (PS) with 2
mmol/l EDTA and 10% D2O. Samples were measured in 5
mm cuvette at 4 jC. 31P-NMR spectra of whole cells were
recorded on VARIAN VXR-300 spectrometer at 121 MHz,
using 45j pulse. Recycle time was 0.8 s. An exponential line
R. Fiala et al. / Biochimica et Biophybroadening of 20 Hz was applied before Fourier transforma-
tion. Final spectrum represents the result of 1024 transients.
Different phosphorus signals were characterised according to
Kaplan et al. [10,30].
2.6. Estimation of ATP and UDP-glucose levels
The level of ATP was estimated according previously
published methods [31]. Cells (106) were pelleted by centri-
fugation (3 min at 1200 g) and washed in ice-cold PBS.
Final pellet was incubated in 1 ml bidistilled water at 98 jC
10 min, coagulated materials were pelleted by centrifugation
(3 min at 3000 g). Aliquots (20 Al) of supernatant were
used for luminometric estimation of ATP levels using lucif-
erin/luciferase reaction in 1 ml of reaction medium contain-
ing 0.1 mol/l arsenate buffer solution pH = 7.4 and 10
Al firefly lantern extract (prepared according to rules given
in the product description from Sigma-Aldrich, St. Louis).
The amount of ATP was calculated from the luminometric
signal and the standard curve obtained by using the solutions
of ATP. The level of UDP glucose was estimated according
to method described by Tang and Sturm [32]. Briefly: cells
(2 107) were pelleted by centrifugation (3 min at 1200 g)
and washed in ice-cold PBS. The pellet was twice extracted
by 0.5 ml of 60% ethanol at 60 jC for 15 min. The extract
was cleared by centrifugation and supernatant was dried in
vacuum drier and resolved in 50 Al of 0.1 mol/l Tris–HCl
buffer pH = 8.5. This solution was used for spectrophoto-
metric estimation of UDP-glucose using NAD/UDP-glucose
dehydrogenase reaction in 200 Al of reaction medium con-
taining 0.1 mol/l Tris–HCl buffer, pH = 8.5, 1.5 mmol/l NAD
and 0.02 units of UDP/glucose. The absorbance of mixture
was monitored in time intervals of 0–60 min. The amounts
of UDP/glucose were calculated from absorbance differ-
ences and standard curve obtained by using the solutions
of UDP-glucose.
2.7. Histochemical staining of the cell surface with
ruthenium red and electron microscopy
The cells were spun down by centrifugation (3 min at
1200 g) and washed in PS. The pellet was stained with 0.5
mg/ml ruthenium red in PS for 60 min at 37 jC, fixed with
2% glutaraldehyde in 0.1 mol/l Na-cacodylate buffer (pH
7.3) with 0.5 mg/ml RR for 75 min, and washed (3 10
min) in the same buffer with RR. Next the pellet was post-
fixed with 1% OsO4 in the same buffer with RR for 75 min,
then washed 3 10 min in a water solution of RR (0.5 mg/
ml) and 2 min in 0.5 mg/ml RR in 50% ethanol. After
dehydration in absolute ethanol, the samples were cleared in
propylene oxide and embedded in Durcupan. Ultrathin
sections were cut with an ultramicrotome Porter-Blum
MT2 from the periphery of the pellets where the RR staining
was maximal [33] and examined in a JEOL JEM 1200 EX
electron microscope at 80 kV, either unstained or stained
with lead citrate.2.8. Affinity chromatography of intracellular glycoproteins
on ConA-Sepharose
The cells were pelleted by centrifugation (3 min at
1200 g), washed four times in PS, finally resuspended
in water (100 Al per 5 107 cells) and frozen. After
thawing off, four volumes of ice-cold buffer H (20 mmol/
l Tris–HCl, 1 mmol/l EGTA, 1 mmol/l DTT, and 0.5
mmol/l PMSF, pH 7.4) were added and the cells were
homogenised by a Teflon-pestle in an Eppendorf tube. The
homogenate was spun down at 10000 g for 30 min at 4
jC and the supernatant representing a cytosolic fraction
was taken for affinity chromatography. The cytosolic frac-
tion containing 1.2–3.3 mg of proteins (protein content
determined according to Bradford) was diluted approxi-
mately 4 with buffer A (50 mmol/l acetate buffer, pH
4.8, with 0.1 mol/l NaCl) and loaded on a minicolumn of
ConA-Sepharose (4.5 1 cm, 1 ml of gel, flow rate of 0.5
ml/min), equilibrated with buffer A containing 0.1 mmol/
l MnCl2 and 0.1 mmol/l CaCl2. Unbound proteins were
washed out with 10 of column volume of buffer A,
followed by elution with 15 bed volumes of 0.15 mol/
l methyl-a-D-mannopyranoside [34] in buffer A (washing
and elution was carried out at 6 jC and at the flow rate
maximally 0.25 ml/min). Samples of cytosolic fractions and
of proteins bound and unbound to ConA were dialysed
against water at 4 jC, lyophilised, diluted in water and
subjected to SDS-PAGE in 5–15% gradient polyacryl-
amide gels according to the method of Laemmli [35].
The proteins were silver-stained.
2.9. Effect of Concanavalin A on the viability of sensitive
and resistant cells
The sensitive and resistant cell lines were cultivated in the
absence or presence of 0.5–25 mg/l of Concanavalin A
(ConA). ConA was added directly to the growth medium
with an inoculum of cells (final concentration 104 cells/ml).
After a cultivation period of 3 days, the cells were stained
with methylene blue, counted in a haemocytometer and the
IC50 values were determined.
2.10. Estimation of the level of glycogen
The cells were pelleted by centrifugation (3 min at
1200 g), washed three times in PS, counted in a haemo-
cytometer, and finally resuspended in 0.2 mol/l Na2CO3
(100 Al per 5 106 cells). The suspension was boiled on
water for 75 min, then cooled down and spun down at
10000 g for 15 min. In the supernatant, the content of
proteins according to Bradford and the level of glycogen
were determined. Sample (240 Al) of extracted glycogen
was neutralised with 5.25 mol/l acetic acid (30 Al), resulting
in 0.5 mol/l acetate buffer, pH 4.8 (buffer G). After a short
vortexing and spinning down (10000 g, 5 min) the
supernatant was divided into two parts, each of 135 Al, to
sica Acta 1639 (2003) 213–224 215
Fig. 1. Overexpression of Pgp in L1210/VCR cells. a—RT-PCR of total cellular RNA was performed with primers for mdr1-specific and h-actin-specific
sequences (see Materials and methods); b—detection of Pgp from the crude membrane protein fractions by Western blot using C219 monoclonal antibody; S—
sensitive cells; R—resistant cells; Rv—resistant cells cultivated in the presence of 0.2 mg/l vincristine.
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water was added, the latter to determine the background.
After incubating for 1 h at 37 jC, glucose levels in both
parts were determined in 50 Al triplicates. Various concen-
trations of glucose in buffer G were taken for calibration. As
a blank, buffer G was used. To each sample (50 Al of each),
glucose oxidase (256 nkat in 50 Al), peroxidase (25 nkat in
50 Al) and 1,2-phenylenediamine (2 mg/ml) were added andFig. 2. Stability of vincristine resistance of L1210/VCR cells. Panel a: sensitivity
L1210/VCR cells (same curve was obtained if the cells were cultivated one time in
15 times in the absence of vincristine. Panel b: IC50 values for vincristine obta
estimation in the absence of vincristine (R) or presence of 0.2 mg/l of vincristine
vincristine (R15). Data on panels 1 and 2 represent meanF S.E. from six independ
h-actin obtained by RT-PCR of total cellular mRNA using primers for mdr1-speci
Rv, and R15 were described for panel b.incubated 1 h at 37 jC. After adding 50 Al of 10% H2SO4,
absorbance at 492 nm was measured in 96-well plates on
Labsystem Multiscan MCC/340 and glucose concentrations
were determined. The background concentration values (i.e.
concentration values corresponding to samples without
amyloglucosidase) were subtracted from the foreground.
The glucose concentrations were considered as the glycogen
ones.of cells to vincristine. Triangles—sensitive L1210 cells. Circles—resistant
the absence of vincristine). Squares—resistant L1210/VCR cells cultivated
ined for cells: sensitive L1210 (S), resistant L1210/VCR cultivated prior
(Rv) and resistant L1210/VCR cells cultivated 15 times in the absence of
ent measurements. Panel c: records of mRNA encoding P-glycoprotein and
fic and h-actin-specific sequences (see Materials and methods). Symbols R,
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3.1. Overexpression of Pgp and resistance of L1210/VCR
cells to vincristine
Overexpression of Pgp in resistant cells was assessed at
the level of mRNA (Fig. 1a) and at the level of proteins
(Fig. 1b). Resistant cells contain mRNA encoding Pgp and
the membrane protein (170 kDa) interacting with C219Fig. 3. 31P-NMR spectra for sensitive and resistant cells. S—sensitive L1210 cells,
0.2 mg/l vincristine; PME—phosphomonoesters; PL/PC—phosphoethanolamin
phosphate groups in a, h and g position resonating at different frequencies. Simiantibody. Neither was detectable in sensitive cells. L1210/
VCR cells exert high levels of resistance to vincristine
(Fig. 2a) which could be characterised by about 200 times
higher IC50 value for resistant cells than sensitive cells
(Fig. 2b). This acquired resistance of L1210/VCR cells is
extremely stable and cultivation of cells in medium without
vincristine did not influence cell sensitivity to vincristine
significantly (Fig. 2b). Decrease of IC50 value for vincris-
tine to one-half was observed when L1210/VCR cells wereRv—resistant L120/VCR cells cultivated prior estimation in the presence of
e/phosphocholine, Pi—inorganic phosphate, a, h, g-ATP—three ATP
lar records were obtained for three independent cultivations.
Table 1
The levels of ATP and UDP-glucose in parental L1210 (S) and multidrug
resistant L1210/VCR cells cultivated prior estimations in the absence (R)
and presence of 0.2 mg/l vincristine (Rv)
S R Rv
UDP-glucose (nmol/mg) 2.72F 0.15 V 0.60 V 0.60
ATP (nmol/mg) 52.48F 2.56 33.92F 3.28 25.92F 1.92
Data represent meanF S.E. from three independent experiments.
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2b), i.e. the resulting cells were about 100 times less
sensitive to vincristine as parental L1210 cells. Simple
cultivation of resistant cells in medium without vincristine
did not induce significant changes in content of mRNA
encoding Pgp, but recultivation of resistant cells 15 times
in the same medium gently depressed the level of this
mRNA (Fig. 2c).Fig. 4. Ultrastructural appearance of RR stained sensitive L1210 and multidrug
periphery of sensitive cells (a,b) and a lower density of RR in multidrug resistant c
(e,f) of vincristine. Magnification bars: 2 Am (a,c,e) and 0.5 Am (b,d,f).3.2. 31P-NMR spectroscopy of sensitive and resistant cells
NMR spectra were undertaken to compare the extent of
changes in phosphorylated metabolites between sensitive
and resistant cells (the latter cultivated in the presence of
0.2 mg/l vincristine, Fig. 3). Comparing the spectra of
sensitive and resistant cells, in resistant cells we can find:
(i) reduction of the ATP level monitored by phosphorus
signals of ATP a-, h- and g-phosphate; (ii) fade away of
phosphorus signal characteristic for UDP-saccharides; (iii)
decrease of signals for phosphomonoesters–phosphoetha-
nolamine and phosphocholine. In our experiments, the
changes in creatine phosphate as well as phosphodiesters
were undetectable due to their low amount in samples
and/or their fast degradability. The difference in the level
of ATP between sensitive L1210 and resistant L1210/
VCR cells obtained from 31P-NMR was verified by
sica Acta 1639 (2003) 213–224resistant L1210/VCR cells. A heavily stained compact layer of RR at the
ells cultivated prior fixation in the presence (0.2 mg/l c,d) or in the absence
R. Fiala et al. / Biochimica et Biophyenzyme estimation procedure using luciferin/luciferase
reaction. The differences in UDP-saccharide contents
between sensitive and resistant cells were also monitored
by estimation of UDP-glucose (major UDP-saccharide)
content using NAD/UDP-glucose dehydrogenase reaction
(Table 1).
We established the amount of UDP-glucose on
2.72F 0.15 nmol/mg of proteins in sensitive cells (Table
1), while amounts of UDP-glucose in resistant cells and
resistant cells cultivated prior to estimation in vincristine
were less than 0.6 nmol/mg of proteins, i.e. the minimal
value that can be estimated according to our experimen-
tal conditions. The level of ATP in resistant cells was
about 35% lower as in sensitive cells (Table 1). Culti-
vation of resistant cells in medium containing 0.2 mg/
l vincristine caused additional decrease of ATP level to
about 50%.
3.3. Histochemical staining of the cell surface by RR
Sialic acid is the main constituent of cell surface
negatively charged sites, which can be visualised by
the polycationic dye RR [36,37]. We can clearly see
that while RR forms a compact layer on the surface of
the sensitive cells (Fig. 4a,b), in the resistant cells, the
layer is either reduced or completely absent, regardless of
the presence of the cytostatic drug (Fig. 4c,d in the
presence, and Fig. 4e,f in the absence of vincristine).
Furthermore, in the case of resistant cells grown in the
presence of vincristine (Fig. 4c), an increased segmenta-
tion of the cell surface and a higher number of vacuoles
are evident.Fig. 5. Effect of ConA on the viability of sensitive and resistant cells. Cells cultiv
stained with methylene blue, counted in a haemocytometer and the IC50 values
viability of sensitive (.) and resistant cells (E); b—the concentration of ConA, at w
L1210/VCR cells cultivated prior estimation in the absence of vincristine.3.4. Effect of ConA on the viability of the cells
We examined the effect of increasing concentrations of
ConA in the cultivation medium on the viability of sensitive
and resistant cells (Fig. 5a). The IC50 value for ConA is 2.8-
fold higher for resistant than for sensitive cells (Fig. 5b). This
means that resistant cells are able to endure higher concen-
trations of ConA than sensitive cells do.
3.5. Differences in the content and spectrum of intracellular
glycoproteins interacting with ConA between sensitive and
resistant cells
Pools of cell lysates originated from sensitive and resis-
tant cells cultivated in the absence or presence of vincristine
were loaded on a column packed with ConA-Sepharose.
Bound proteins were eluted from the column using a-
methyl-D-mannopyranoside. Material balance of bound and
unbound proteins is given in Fig. 6. While the whole protein
content in sensitive and resistant cells were not significantly
different, the proportion of glycoproteins interacting with
ConA to whole proteins in resistant cells was significantly
lower than in sensitive cells. Cultivation of resistant cells in
the medium containing vincristine partially reversed this
behaviour. The collected unbound and bound proteins were
analysed by SDS-PAGE. Several alterations in the spectrum
of (glyco)proteins are evident from Fig. 7. A 67 kDa protein
band present in large amount in sensitive cells in the protein
fraction not interacting with ConA-Sepharose is remarkably
decreased in resistant cells. On the other hand, two bands of
about 38 and 48 kDa in the same fraction coming from
resistant cells (independently of the presence of vincristine
sica Acta 1639 (2003) 213–224 219ated in the absence or presence of increasing concentrations of ConA were
were determined. a—Effect of increasing concentrations of ConA on the
hich half of the cells survive (IC50); S—sensitive L1210 cells; R—resistant
Fig. 6. Binding of extracted cytosolic proteins from sensitive and resistant cells to ConA column. a—Content of total cytosolic proteins isolated from cells; b—
content of cytosolic proteins bound and unbound to ConA column; S—sensitive cells; R—resistant cells cultivated without vincristine; Rv—resistant cells
cultivated in the presence of 0.2 mg/l vincristine; (ConA ) proteins that were unbound to the ConA column, (ConA+) proteins that were bound to the ConA
column.
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In the fraction of ConA-interacting proteins, lower amounts
of proteins corresponding to the bands of about 48 and 67Fig. 7. SDS-PAGE of cytosolic proteins isolated from sensitive L1210 (S) and re
were separated in gradient 5–15% polyacrylamide gels and silver-stained. a—un
cells; R—resistant cells cultivated without vincristine; Rv—resistant cells cultiva
Molecular weight values of the marker are indicated in kilodaltons on the left.
differences are marked with arrows.kDa are observed in sensitive as in resistant cells (regardless
of the presence of vincristine during cultivation of the latter
cells). In contrast, the same fraction of sensitive cells con-sistant L1210/VCR (R) cells unbound or bound to ConA. Protein fractions
bound proteins (flow-through); b—proteins bound to ConA; S—sensitive
ted in the presence of 0.2 mg/l vincristine; M—molecular weight marker.
Several alterations in the spectrum of glycoproteins were observed. The
Fig. 8. The level of intracellular glycogen in sensitive L1210 and resistant
L1210/VCR cells. Glycogen was determined enzymatically in cell lysates
and expressed relative to the whole cell protein mass. S—Sensitive cells;
R—resistant cells; Rv—resistant cells cultivated in the presence of 0.2 mg/l
vincristine.
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between 34 and 41 kDa.
3.6. Glycogen content in sensitive and resistant cells
The amount of glycogen was expressed relative to the
whole cell protein mass. The amount of glycogen is signif-
icantly decreased in resistant cells in comparison with
sensitive cells. The presence of vincristine does not cause
any further significant changes in the level of glycogen in
resistant cells (Fig. 8).4. Discussion
Two types of cell models may be used in studies of
function of Pgp in MDR, cells with a stable transfection or
cells adapted to cytotoxic Pgp substrate. Cells with a stable
transfection of Pgp enable to measure the functional prop-
erties of Pgp with a sufficient accuracy. However, in this
model, overexpression of Pgp is not associated with several
other changes of cell metabolism, which occur frequently
during adaptation of cancer cells to cytostatics. This may be
exemplified by the finding of up-regulation of caveolae and
caveolar constituents only in MCF-7 cells overexpressing
Pgp due to adaptation to adriamycin in contrast to the
MCF-7 cells overexpressing Pgp but not caveolar constit-
uents due to stable transfection by mdr1 gene [38]. There-
fore, to obtain comprehensive information on Pgp-mediated
MDR phenotype, cells adapted to cytostatics should be
used.
Pgp-mediated MDR phenotype of L1210/VCR cells is
documented in Fig. 1. Multidrug resistance of these cells andoverexpression of Pgp persists in cells after repeating culti-
vation in medium without vincristine (Fig. 2). Previously we
have found that Pgp is a dominant system securing the
resistance of our cells to several cytostatics [15]. Thus, this
cell line represents an appropriate model for the study of
processes associated with overexpression of Pgp in neoplas-
tic cells after their adaptation.
In several MDR cells, an increased level of glycolysis was
observed [9]. In L1210/VCR cells exposed to vincristine we
previously described an increase in glucose incorporation, a
higher degree of mitochondrial condensation and an in-
creased utilisation of oxygen [14,22]. Similar changes of
mitochondria and also an acceleration of oxidative way of
ATP production were observed by Jia et al. [39,40] in Pgp-
positive CEM/VLB100 cell line.
All these results probably point to the acceleration of both
ATP production in mitochondria and ATP degradation due to
increased energy requirements arising as a consequence of
the Pgp-mediated extrusion of cytostatic drugs entering the
intracellular space via passive diffusion [41–43]. Thus,
acceleration of ATP production and the reduction of ATP
level are not mutually exclusive.
31P-NMR spectroscopy revealed the reduction of ATP
level and the decrease of the level of UDP-saccharides and
phosphomonoesters in resistant cells (Fig. 3). In our cell line,
i.e. L1210/VCR, Ujha´zy et al. [44] also described a reduction
of intracellular ATP concentration that was associated with
an increase in 5V-nucleotidase expression and/or activity. In
agreement with this, we estimated reduction of ATP content
by about 35% in resistant cells as compared with sensitive
cells (Table 1). Cultivation of cells in the presence of
vincristine induced additional depression in ATP level to
50% as compared with sensitive cells. In contrast, Kaplan et
al. [10] performed 31P-NMR spectroscopy on sensitive and
resistant cells and observed an increase in ATP concentration
in majority of resistant cell lines. These authors also state that
the cellular metabolism, including ATP formation and hy-
drolysis, reflected by 31P-NMR spectra may depend on
several factors including the cell line and the drug used to
select cells for MDR. Thus, the direction of changes in levels
of phosphorylated metabolites (including ATP) are not the
same for all cell lines with MDR mediated by Pgp over-
expression. Therefore, changes in 31P-NMR spectra could
not directly reflect the expression of Pgp [10]. One possible
explanation for the reduced level of ATP is that the great
amount of ATP spent by cells in the presence of vincristine is
recovered only partially.
The depression of UDP-saccharides monitored by 31P-
NMR was supported by measurement of UDP-glucose
content as a major UDP-saccharide (Table 1). A steep
decrease in the UDP-saccharide levels (and also UDP-
glucose levels) observed in resistant cells indicates the
depression of transglycosylation reactions and consequently
the reduction of oligo- and polysaccharides synthesis. There-
fore, we have focused on (a) histochemical visualisation of
sialic acid on the cell surface, (b) determining alterations in
R. Fiala et al. / Biochimica et Biophysica Acta 1639 (2003) 213–224222content and spectrum of glycoproteins interacting with
ConA and (c) determining the level of intracellular glycogen.
Sialic acids are anionic polysaccharides, a group of over
40 compounds comprising a nine-carbon pyranose ring [45],
present in a huge amount on the outer side of the plasma
membrane of animal cells and playing an important role in
certain biological processes including malignancy [46].
Their moieties on the cell surface form the binding sites
for several lectins, and influence the degree of cells agglu-
tination [47–49]. Due to their strong negative charge they
can interact with RR—the polycationic dye that has been
used for histochemical staining of sialic acids in the external
cell coat [36,37]. The results of electron microscopic inves-
tigation show that a compact layer of RR stained material
coats sensitive cells (Fig. 4a,b) and, on the contrary, that in
resistant cells this layer is either reduced or absent, indepen-
dently on the presence of vincristine (Fig. 4c–f). This
difference in the thickness of the RR stained coat was much
larger than that between cells in different phases of the cell
cycle as studied in a human lymphoblastoid line [50].
Lectin ConA has been shown to agglutinate malignant or
transformed cells [51–53]. It has been shown that ConA
binds to external saccharides of the cell surface [49]. Csuka
and Suga´r [54] compared a vincristine-colchicine resistant
subline of L1210 with sensitive L1210 cells. The resistant
subline was less agglutinable than the sensitive subline. In
our experiments (Fig. 5), IC50 value for ConA was 2.8-fold
higher for resistant L1210/VCR as for sensitive L1210 cells
(Fig. 5). The latter result could be simply explained by an
assumption that the cell surface of resistant cells, as com-
pared to sensitive cells, contains lower amount of saccha-
rides. Thus, ConAwill cross-link and consequently affect the
viability of resistant cells less effectively as sensitive cells.
This finding is consistent with our results of RR staining.
Beside saccharides being present on the cell surface,
ConA may interact with a wide spectrum of intracellular
glycoproteins. Chromatography on ConA-Sepharose has
been recently described as advantageous method for analysis
of glycoproteins originated from colorectal adenocarcinoma
biopsies [55]. In our experiments, the decrease in protein
proportion interacting with ConA-Sepharose has been found
in resistant cells (Fig. 6). Interestingly, cultivation of resistant
cells in the presence of vincristine induces a partial recovery
of intracellular glycoprotein formation (Fig. 6b). This is
probably caused by importance of specific glycoproteins in
the resistant cells growing in the presence of vincristine.
When glycoprotein spectra from resistant cells cultivated in
the absence or presence of vincristine were compared, an
increase in low molecular weight glycoproteins was ob-
served in cells under the effect of vincristine (Fig. 7a).
Several other alterations in the spectrum of glycoproteins
were observed when sensitive and resistant cells were
compared (Fig. 7). This points to differences in glycopeptide
and glycoprotein formation associated with development of
MDR phenotype. Thus, sensitive and resistant cells also
differ in protein glycosylation.The changes in intracellular glycogen level could be
directly related to the observed decrease in the level of
UDP-glucose and to the assumed increase in energy
demands in L1210/VCR cells. Indeed, the amount of glyco-
gen is significantly decreased in resistant cells independently
on the presence of vincristine in cultivation medium in
comparison with sensitive cells (Fig. 8). Similar behaviour
was observed for UDP-glucose (Table 1) and may be
deduced for sialic acid from the results of RR staining
(Fig. 4). This indicates that MDR phenotype of L1210/
VCR cells includes depressions in levels of these three
substances independently on the presence of substances that
are substrates and are extruded by Pgp. Thus, it could also be
pointed out that in the absence of vincristine, the over-
expression of Pgp (see Figs. 1 and 2) in L1210/VCR cells
is associated with changes of cell metabolism due probably
to the selection pressure of vincristine during the adaptation
period. These changes, together with Pgp overexpression,
are involved in the phenotype associated with MDR charac-
ter of these cells.
Finally, we can summarise that MDR character of L1210/
VCR cells mediated by Pgp is accompanied by depression of
poly- and/or oligosaccharide biosynthesis. The question of
this feature being characteristic for L1210/VCR cells, or
common for other cells with MDR phenotype mediated
predominantly by Pgp, has to be resolved in the future.Acknowledgements
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